How many institutions held KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares in Q3 2021?

14 institutional investors reported KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares for Q3 2021. Use the holders table for investor-level position and value details.

KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA)

Q: What does CUSIP 48669G105 represent in this 13F holders report?

CUSIP 48669G105 is the security identifier for KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares used to aggregate holder disclosures.

CUSIP: 48669G105

Q3 2021 13F Holders as of 30 Sep 2021

Security type / class: Equity / American Depositary Shares
Total 13F shares: 539,906
Total 13F value: $5,029,362
Share change: +3,745
Put/Call ratio: 0%
SEC-reported price per share: $11.33
Number of holders: 14
Value change: +$81,288
Number of buys: 7
Number of sells: 3
Shares outstanding: 11,430,535

Security key

48669G105

Report period

Q3 2021

Institutions

Top holders

KZIA full security history Ownership snapshot Full 13F holder table KAZIA THERAPEUTICS LTD SEC filings KAZIA THERAPEUTICS LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of KZIA - KAZIA THERAPEUTICS LTD - American Depositary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MORGAN STANLEY

Disclosed value leader

MORGAN STANLEY

Comparable rows

12/12

Latest evidence

30 Jun 2021

13F Lead comparable stake: 2% Showing 1-6 of 12 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 2%.

12 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.

Comparable ownership Top 5

MORGAN STANLEY 2%

Transform Wealth, LLC 0.93%

RENAISSANCE TECHNOLOGIES LLC 0.58%

SG Americas Securities, LLC 0.39%

TRUIST FINANCIAL CORP 0.25%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 12 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MORGAN STANLEY	13F Company 13F	2%	$2,307,000 233,953 shares	—	30 Jun 2021
Transform Wealth, LLC	13F Company 13F	0.93%	$104,000 106,245 shares	—	30 Jun 2021
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	0.58%	$649,000 65,823 shares	—	30 Jun 2021
SG Americas Securities, LLC	13F Company 13F	0.39%	$438,000 44,398 shares	—	30 Jun 2021
TRUIST FINANCIAL CORP	13F Company 13F	0.25%	$287,000 29,020 shares	—	30 Jun 2021
ACT CAPITAL MANAGEMENT, LLC	13F Company 13F	0.22%	$247,000 25,000 shares	—	30 Jun 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

539,906

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders

Q3 2021 holders

Holder diff

Investor	Q2 2021 Shares	Q3 2021 Shares	Share Diff	Share Chg %	Q2 2021 value	Q3 2021 value	Value change	Value Chg %